Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems

Autor: Tali Kizhner, Myriam Golembo, David Aviezer, Anna Gantman, Mariana Hainrichson, Salit Tzaban, Yoseph Shaaltiel, Yoram Tekoah
Rok vydání: 2013
Předmět:
Male
β-glucocerebrosidase
Glycosylation
Mannose
Gaucher disease
Biochemistry
2AB
2-aminobenzamide

ICR
imprinting control region

law.invention
Mice
chemistry.chemical_compound
law
Enzyme Stability
Carbohydrate Conformation
MALDI–TOF-MS
matrix-assisted laser desorption ionization–time-of-flight-MS

Tissue Distribution
chemistry.chemical_classification
Mice
Inbred ICR

GU
glucose unit

GD
Gaucher disease

PNGase F
peptide N-glycosidase F

Recombinant Proteins
Taliglucerase alfa
ERT
enzyme replacement therapy

Carbohydrate Sequence
lysosomal storage disease
Recombinant DNA
Glucosylceramidase
ERT
medicine.drug
HSD
honestly significant difference

SA
sialic acid

Imiglucerase
Molecular Sequence Data
Biophysics
PNGase A
peptide N-glycosidase A

macrophage
Biology
PNP-G
p-nitrophenyl β-D-glucopyranoside

S2
Cell Line
4MU-G
4-methylumbelliferyl β-D-glucopyranoside

Macrophages
Alveolar

NP
normal phase

medicine
Animals
Humans
Molecular Biology
MBL
mannose-binding lectin

Original Paper
Velaglucerase alfa
Biological Transport
Cell Biology
MR
mannose receptor

Rats
Kinetics
Enzyme
chemistry
CHO
Chinese-hamster ovary

Protein Processing
Post-Translational

Glucocerebrosidase
DAPI
4′
6-diamidino-2-phenylindole
Zdroj: Bioscience Reports
ISSN: 1573-4935
0144-8463
DOI: 10.1042/bsr20130081
Popis: The glycosylation of recombinant β-glucocerebrosidase, and in particular the exposure of mannose residues, has been shown to be a key factor in the success of ERT (enzyme replacement therapy) for the treatment of GD (Gaucher disease). Macrophages, the target cells in GD, internalize β-glucocerebrosidase through MRs (mannose receptors). Three enzymes are commercially available for the treatment of GD by ERT. Taliglucerase alfa, imiglucerase and velaglucerase alfa are each produced in different cell systems and undergo various post-translational or post-production glycosylation modifications to expose their mannose residues. This is the first study in which the glycosylation profiles of the three enzymes are compared, using the same methodology and the effect on functionality and cellular uptake is evaluated. While the major differences in glycosylation profiles reside in the variation of terminal residues and mannose chain length, the enzymatic activity and stability are not affected by these differences. Furthermore, the cellular uptake and in-cell stability in rat and human macrophages are similar. Finally, in vivo studies to evaluate the uptake into target organs also show similar results for all three enzymes. These results indicate that the variations of glycosylation between the three regulatory-approved β-glucocerebrosidase enzymes have no effect on their function or distribution.
Databáze: OpenAIRE